In opening a new route, all airline companies in Indonesia need to get approval from the Ministry of the Transportation Republic of Indonesia. When asking an approval to open a new route, it becomes an important thing and needs careful planning. The national flag carrier of Indonesia, which serves a full-service product to its customers, has plans to open several new domestic and international routes in 2019. Like other Indonesian airlines, it also needs to submit its five-year business plan to get the Air Transport Business Permit (or Surat Izin Usaha Angkutan Udara - SIUAU) from Ministry of Transportation. This paper focuses on several high-frequency domestic routes from/ to Soekarno Hatta International Airport, such as Jakarta – Denpasar, Jakarta – Medan, Jakarta – Semarang, Jakarta – Surabaya, and Jakarta – Yogyakarta. By using both a combination of the Focus Group Discussion (FGD) and the Analytic Hierarchy Process (AHP) methods in selecting the most suitable aircraft type, several criteria and alternatives were defined. 6 (six) important criteria in selecting the most suitable aircraft (Maximum Take Off Weight (MTOW), Cost per Available Seat Kilometer (CASK), operational performance, delivery time, fleet commonality, and additional benefits) and 4 (four) alternative aircraft types (B737-800NG, B737-8MAX, CRJ1000, and A330-300) that are suitable for those routes were defined. The result shows that the most suitable aircraft for highfrequency domestic routes is B737-800NG, which rank first in fleet commonality, operational performance, and delivery time. Then followed by B737-8MAX, A330-300, and CRJ1000. Thus, this study provides an illustration of aircraft type selection problem solving for known routes, which expectedly could help other airline companies in considering more careful planning in the future
BPJS Kesehatan (Badan Penyelenggara Jaminan Sosial Kesehatan) is an agency that liable to organize the nationalhealth security system in Indonesia. The health services director of BPJS Kesehatan has issued three regulations as an effort to control deficits which currently hit since 2014. The issuance of the regulations reaped controversy over its contents governing the limitation of health benefits that assured by BPJS Kesehatan. Besides that, BPJS Kesehatan has assumed not an authorized institution to issue that policy. This study aims to analyze the issuance of the regulations as a public policy. Data collection is obtained by in-depth interviews with top-level management, literature review and observation. Stakeholder analysis used to find out where the position of BPJS Kesehatan in the national health security system environment is. It will help in carrying out its functions and roles to succeed that program. Through stakeholder analysis is known that the government and the participants are the primary stakeholders of the national health security system. While BPJS Kesehatan is an agent representing the government providing health benefits to the participants. BPJS Kesehatan is not the primary stakeholder but secondary stakeholder, then the determination of any health benefits provided to the participants is an authority of the government rather than BPJS Kesehatan. Inaccuracy in the reading relationship between stakeholders could be at risk for BPJS Kesehatan in making a strategic decision. BPJS Health's lack of understanding of its authority, lead to ineffective decision-making and policies. The ineffectiveness of policies or decisions makes the goals of BPJS Health as providers of national health security programs difficult to achieve. By understanding the limits of its authority, BPJS Kesehatan able to take strategic steps according to the company's goals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.